Hormone Replacement Therapy to Decrease Glaucoma Risk

Women, who underwent estrogen-only hormone replacement therapy, had a lower risk of glaucoma development after ovarian removal surgery found a new study. The findings of this study will be discussed at AAO 2017, the 121st Annual Meeting of the American Academy of Ophthalmology.

Related Links